Questions across 3 calls

Lakshminarayanan G

Firm not listed in source transcripts

JSW Dulux Limited

JSW Dulux Limited CC-Feb26.pdf · 2026-02-03

Rajiv, I think there are two or three number questions, and one is very conceptual question. So, first, I want to understand from a decorative volume growth, 9 months to last 9 months, like-for- like, what has been the volume growth? Second question is what are the cash levels we actually carry right now, approximately? And the third is you talked about royalty. I think royalty was around 140 crores or so. So how does the company intend to use it, whether it will flow into the bottom line or you would actually use it for business expansion? How do you think about it? These are the three questions from a number point of view. Conceptually, I want to understand, looking out three years, what will you call a s markers of success for you and the management? It could be market share, it could be revenue growth, or it could be margins or ROC E. When you say that, look, we are successful three years out, what are the two or three markers you like to use and say, okay, we have done well? I think these are the questions, Rajiv.

And volume growth on decorative like-for-like for the 9 months.

JSW Dulux Limited CC-Dec24.pdf · 2025-02-07

Sir, my question is related to -- there has been for the last 90 days or so, there have been enough media as well as company communications saying that your business would be restructured, right? Now my question is that how is the employee morale and the distribution morale because it puts in kind of uncertainty and how as a company you are actually handling it. Are you able to rope in new distributors…?

Got it. I think in terms of new recruitment and -- I mean taking -- empaneling, getting more distributors, is it business as usual on those 2 fronts?

Zydus Wellness Limited

Zydus Wellness Limited CC-Nov25.pdf · 2025-11-05

Sir, a couple of questions. When I just look at the category size of Glucon-D, Complan and Nycil, which was given at the time of you acquiring those brands, they're something like INR850 crores, INR6,700 crores and INR750 crores. When I look at it, they have -- I mean, as we speak right now, Glucon-D has gone from INR850 crores to INR1,050 crores. Complan has gone from INR6,700 crores to INR6,800 crores and Nycil also hasn't gone up. So is there a problem with the category that the category doesn't seem to grow from the time of you acquiring till now? That is number one. Second, if I look at your 2022 data and 2025 data in terms of market share, which you have actually provided, there seems to be a market share drop in Nycil and also in Complan. So I just want to know why category itself is not growing? And second, why on a slightly long-term point of view, like a 3-year point of view, our market share actually have dropped.

Just one question on addition to that, right? So if I look at the category itself, which has been reported, even including Sugar Free, hasn't really grown since acquisition. It's nothing to do with any category of what you -- even you mentioned the category size of Glucon-D, Complan, Nycil and Sugar Free, they have not really grown. They have grown at like 1%, 2%, 3% kind of thing or even stayed flat. So is it -- is that category size also was reported wrongly? Or how do we take this up? Because as investors, we find that the category itself is not growing. However, you are growing, that's one part. But how to think about it?